trial · primary record
PIPE-791 Dose A
Idiopathic Pulmonary Fibrosis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 324 |
| Primary completion | 2028-06 |
| Primary endpoint | Absolute change in forced vital capacity (FVC) (mL) |
| Registry ID | NCT07284459 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:18.881Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07284459
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.